Inventor
MACLEOD CALUM
GB30 patents
⚠️ This page may combine multiple inventors who share the name “MACLEOD CALUM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
13 patentsUS9643964B2May 9, 2017
3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer
JANSSEN PHARMACEUTICA NV9 citations83
US11236084B2Feb 1, 2022
Substituted azaindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11186589B2Nov 30, 2021
Cyanoindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11180487B2Nov 23, 2021
Substituted cyanoindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11136311B2Oct 5, 2021
Heteroaromatic derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11001569B2May 11, 2021
6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US10822342B2Nov 3, 2020
Pyrazolopyrimidine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US10221180B2Mar 5, 2019
Pyrazolopyrimidine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US10005776B2Jun 26, 2018
Compounds as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations40
US10005773B2Jun 26, 2018
1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations40
US10323045B2Jun 18, 2019
Thienopyrimidine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations39
US9981963B2May 29, 2018
3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations39
US9981962B2May 29, 2018
Pyrazole derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations38
GENENTECH INC
9 patentsUS9650393B2May 16, 2017
Benzoxazepin oxazolidinone compounds and methods of use
GENENTECH INC20 citations91
US10851091B2Dec 1, 2020
Benzoxazepin oxazolidinone compounds and methods of use
GENENTECH INC5 citations83
US10112932B2Oct 30, 2018
Benzoxazepin oxazolidinone compounds and methods of use
GENENTECH INC8 citations83
US9440976B2Sep 13, 2016
1,7-diazacarbazoles and methods of use
GENENTECH INC10 citations82
US11760753B2Sep 19, 2023
Benzoxazepin oxazolidinone compounds and methods of use
GENENTECH INC2 citations72
US9643980B2May 9, 2017
Benzoxazepin oxazolidinone compounds and methods of use
GENENTECH INC3 citations72
US9216980B2Dec 22, 2015
Methods of use of diazacarbazoles for treating cancer
GENENTECH INC0 citations50
US10435414B2Oct 8, 2019
Tricyclic PI3K inhibitor compounds and methods of use
GENENTECH INC0 citations48
US10065970B2Sep 4, 2018
Tricyclic PI3K inhibitor compounds and methods of use
GENENTECH INC1 citations48
ENYO PHARMA
4 patentsUS11603368B2Mar 14, 2023
Fused thiophene derivatives and their uses
ENYO PHARMA0 citations57
US11492347B2Nov 8, 2022
Fused thiophene derivatives and their uses
ENYO PHARMA1 citations57
US11279683B2Mar 22, 2022
Thiophene derivatives as antiviral agents
ENYO PHARMA1 citations54
US11807618B2Nov 7, 2023
Thiophene derivatives as antiviral agents
ENYO PHARMA0 citations53